78 related articles for article (PubMed ID: 12646182)
1. New selective amplifier genes containing c-Mpl for hematopoietic cell expansion.
Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
Biochem Biophys Res Commun; 2003 Mar; 303(1):170-6. PubMed ID: 12646182
[TBL] [Abstract][Full Text] [Related]
2. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch.
Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674
[TBL] [Abstract][Full Text] [Related]
3. High-level in vivo gene marking after gene-modified autologous hematopoietic stem cell transplantation without marrow conditioning in nonhuman primates.
Ueda K; Hanazono Y; Shibata H; Ageyama N; Ueda Y; Ogata S; Tabata T; Nagashima T; Takatoku M; Kume A; Ikehara S; Taniwaki M; Terao K; Hasegawa M; Ozawa K
Mol Ther; 2004 Sep; 10(3):469-77. PubMed ID: 15336647
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule-directed mpl signaling can complement growth factors to selectively expand genetically modified cord blood cells.
Richard RE; Blau CA
Stem Cells; 2003; 21(1):71-8. PubMed ID: 12529553
[TBL] [Abstract][Full Text] [Related]
6. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
[TBL] [Abstract][Full Text] [Related]
7. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
8. A preliminary investigation into the action of anagrelide: thrombopoietin-c-Mpl receptor interactions.
McCarty JM; Melone PD; Simanis JP; Kanamori D; Dessypris EN; Warshamana-Greene GS
Exp Hematol; 2006 Jan; 34(1):87-96. PubMed ID: 16413395
[TBL] [Abstract][Full Text] [Related]
9. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells.
Xu R; Kume A; Matsuda KM; Ueda Y; Kodaira H; Ogasawara Y; Urabe M; Kato I; Hasegawa M; Ozawa K
J Gene Med; 1999; 1(4):236-44. PubMed ID: 10738556
[TBL] [Abstract][Full Text] [Related]
10. Surrogate thrombopoietin.
Abe M; Yano S; Sakaba N; Kitamura K; Urasaki T; Nakada S; Kawasaki H; Morimoto C; Masuho Y
Immunol Lett; 1998 Apr; 61(2-3):73-8. PubMed ID: 9657257
[TBL] [Abstract][Full Text] [Related]
11. Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs.
Dahlen DD; Broudy VC; Drachman JG
Blood; 2003 Jul; 102(1):102-8. PubMed ID: 12623841
[TBL] [Abstract][Full Text] [Related]
12. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
13. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
14. Cloning and functional characterization of a novel c-mpl variant expressed in human CD34 cells and platelets.
Li J; Sabath DF; Kuter DJ
Cytokine; 2000 Jul; 12(7):835-44. PubMed ID: 10880227
[TBL] [Abstract][Full Text] [Related]
15. Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization.
Richard RE; Wood B; Zeng H; Jin L; Papayannopoulou T; Blau CA
Blood; 2000 Jan; 95(2):430-6. PubMed ID: 10627446
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
17. Embryonic stem cell differentiation to hematopoietic cells: A model to study the function of various regions of the intracytoplasmic domain of cytokine receptors in vitro.
Filippi MD; Porteu F; Le Pesteur F; Rameau P; Nogueira MM; Debili N; Vainchenker W; de Sauvage FJ; Kupperschmitt AD; Sainteny F
Exp Hematol; 2000 Dec; 28(12):1363-72. PubMed ID: 11146158
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the extracellular membrane-distal cytokine receptor homology module of Mpl results in constitutive cell growth and loss of thrombopoietin binding.
Sabath DF; Kaushansky K; Broudy VC
Blood; 1999 Jul; 94(1):365-7. PubMed ID: 10381535
[TBL] [Abstract][Full Text] [Related]
19. Signaling by the Mpl receptor involves IKK and NF-kappaB.
Zhang Y; Sun S; Wang Z; Thompson A; Kaluzhny Y; Zimmet J; Ravid K
J Cell Biochem; 2002; 85(3):523-35. PubMed ID: 11967992
[TBL] [Abstract][Full Text] [Related]
20. Membrane localization is not required for Mpl function in normal hematopoietic cells.
Otto KG; Broudy VC; Lin NL; Parganas E; Luthi JN; Drachman JG; Ihle JN; Blau CA
Blood; 2001 Oct; 98(7):2077-83. PubMed ID: 11567993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
